Abstract |
Somatostatin receptor 2 (SSTR2) is frequently overexpressed on several types of solid tumors, including neuroendocrine tumors and small-cell lung cancer. Peptide agonists of SSTR2 are rapidly internalized upon binding to the receptor and linking a toxic payload to an SSTR2 agonist is a potential method to kill SSTR2-expressing tumor cells. Herein, we describe our efforts towards an efficacious SSTR2-targeting cytotoxic conjugate; examination of different SSTR2-targeting ligands, conjugation sites, and payloads led to the discovery of 22 (PEN-221), a conjugate consisting of microtubule-targeting agent DM1 linked to the C-terminal side chain of Tyr3-octreotate. PEN-221 demonstrates in vitro activity which is both potent (IC50 = 10 nM) and receptor-dependent (IC50 shifts 90-fold upon receptor blockade). PEN-221 targets high levels of DM1 to SSTR2-expressing xenograft tumors, which has led to tumor regressions in several SSTR2-expressing xenograft mouse models. The safety and efficacy of PEN-221 is currently under evaluation in human clinical trials.
|
Authors | Brian H White, Kerry Whalen, Kristina Kriksciukaite, Rossitza Alargova, Tsun Au Yeung, Patrick Bazinet, Adam Brockman, Michelle DuPont, Haley Oller, Charles-Andre Lemelin, Patrick Lim Soo, Benoît Moreau, Samantha Perino, James M Quinn, Gitanjali Sharma, Rajesh Shinde, Beata Sweryda-Krawiec, Richard Wooster, Mark T Bilodeau |
Journal | Journal of medicinal chemistry
(J Med Chem)
Vol. 62
Issue 5
Pg. 2708-2719
(03 14 2019)
ISSN: 1520-4804 [Electronic] United States |
PMID | 30735385
(Publication Type: Journal Article)
|
Chemical References |
- Antineoplastic Agents, Phytogenic
- Immunoconjugates
- Receptors, Somatostatin
- Maytansine
- somatostatin receptor 2
|
Topics |
- Animals
- Antineoplastic Agents, Phytogenic
(chemistry, pharmacokinetics, pharmacology)
- CHO Cells
- Cell Line
- Cricetulus
- Dogs
- Drug Discovery
- Humans
- Immunoconjugates
(chemistry, pharmacology)
- Maytansine
(chemistry, pharmacokinetics, pharmacology)
- Mice
- Receptors, Somatostatin
(drug effects, metabolism)
- Xenograft Model Antitumor Assays
|